Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.11)
# 1,230
Out of 4,839 analysts
493
Total ratings
35.73%
Success rate
3.15%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALA KALA BIO | Maintains: Buy | $15 → $12 | $3.93 | +205.59% | 22 | May 23, 2025 | |
| VANI Vivani Medical | Reiterates: Buy | $4 | $1.13 | +253.98% | 6 | May 19, 2025 | |
| SMTI Sanara MedTech | Maintains: Buy | $51 → $53 | $30.59 | +73.26% | 4 | May 15, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $100 | $61.24 | +63.29% | 19 | May 15, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $21.69 | +38.31% | 2 | May 13, 2025 | |
| HROW Harrow | Maintains: Buy | $57 → $60 | $25.84 | +132.20% | 4 | May 12, 2025 | |
| CDNA CareDx | Reiterates: Neutral | $25 | $17.01 | +46.97% | 12 | May 5, 2025 | |
| OKYO OKYO Pharma | Reiterates: Buy | $7 | $1.88 | +272.34% | 13 | May 5, 2025 | |
| TRML Tourmaline Bio | Reiterates: Buy | $50 | $15.37 | +225.41% | 7 | May 5, 2025 | |
| BLCO Bausch + Lomb | Maintains: Buy | $20 → $15 | $11.15 | +34.53% | 18 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $8 | $2.25 | +255.41% | 22 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $11.26 | +24.33% | 9 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.04 | +196.05% | 18 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $9.86 | +295.54% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $32 | $18.42 | +73.72% | 14 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.52 | +377.19% | 2 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.76 | +165.96% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.27 | +137.15% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $9.30 | +72.04% | 10 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.66 | +157.51% | 19 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $2.67 | +349.27% | 4 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.86 | +597.76% | 20 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.04 | +188.46% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.23 | +326.99% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.01 | +147.52% | 20 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.05 | +227.87% | 16 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.54 | +175.59% | 19 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.76 | +296.77% | 13 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $9.43 | +260.55% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.59 | +293.56% | 21 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $7.21 | +108.04% | 26 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $1.08 | +548.15% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.49 | +515.13% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.09 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $75 | $0.55 | +13,523.98% | 18 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.27 | +3,603.70% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.31 | +3,446.10% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.88 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $15.52 | +209.28% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $640 | $1.75 | +36,471.43% | 5 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $10.76 | +76.66% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.19 | - | 2 | Apr 16, 2020 |
KALA BIO
May 23, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $3.93
Upside: +205.59%
Vivani Medical
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.13
Upside: +253.98%
Sanara MedTech
May 15, 2025
Maintains: Buy
Price Target: $51 → $53
Current: $30.59
Upside: +73.26%
Belite Bio
May 15, 2025
Reiterates: Buy
Price Target: $100
Current: $61.24
Upside: +63.29%
BioLife Solutions
May 13, 2025
Reiterates: Buy
Price Target: $30
Current: $21.69
Upside: +38.31%
Harrow
May 12, 2025
Maintains: Buy
Price Target: $57 → $60
Current: $25.84
Upside: +132.20%
CareDx
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $17.01
Upside: +46.97%
OKYO Pharma
May 5, 2025
Reiterates: Buy
Price Target: $7
Current: $1.88
Upside: +272.34%
Tourmaline Bio
May 5, 2025
Reiterates: Buy
Price Target: $50
Current: $15.37
Upside: +225.41%
Bausch + Lomb
May 2, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $11.15
Upside: +34.53%
Apr 30, 2025
Maintains: Buy
Price Target: $15 → $8
Current: $2.25
Upside: +255.41%
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $11.26
Upside: +24.33%
Apr 29, 2025
Reiterates: Buy
Price Target: $9
Current: $3.04
Upside: +196.05%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $9.86
Upside: +295.54%
Apr 17, 2025
Maintains: Buy
Price Target: $29 → $32
Current: $18.42
Upside: +73.72%
Apr 11, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.52
Upside: +377.19%
Apr 9, 2025
Initiates: Buy
Price Target: $10
Current: $3.76
Upside: +165.96%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.27
Upside: +137.15%
Apr 7, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $9.30
Upside: +72.04%
Apr 4, 2025
Reiterates: Buy
Price Target: $12
Current: $4.66
Upside: +157.51%
Apr 4, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.67
Upside: +349.27%
Mar 31, 2025
Reiterates: Buy
Price Target: $6
Current: $0.86
Upside: +597.76%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $1.04
Upside: +188.46%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.23
Upside: +326.99%
Mar 28, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.01
Upside: +147.52%
Mar 28, 2025
Reiterates: Buy
Price Target: $10
Current: $3.05
Upside: +227.87%
Mar 25, 2025
Reiterates: Buy
Price Target: $7
Current: $2.54
Upside: +175.59%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $0.76
Upside: +296.77%
Mar 21, 2025
Reiterates: Buy
Price Target: $34
Current: $9.43
Upside: +260.55%
Mar 6, 2025
Reiterates: Buy
Price Target: $22
Current: $5.59
Upside: +293.56%
Mar 4, 2025
Reiterates: Buy
Price Target: $15
Current: $7.21
Upside: +108.04%
Jan 24, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.08
Upside: +548.15%
Jan 2, 2025
Reiterates: Buy
Price Target: $3
Current: $0.49
Upside: +515.13%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.09
Upside: -
Jun 10, 2024
Maintains: Buy
Price Target: $350 → $75
Current: $0.55
Upside: +13,523.98%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.27
Upside: +3,603.70%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.31
Upside: +3,446.10%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.88
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $15.52
Upside: +209.28%
Apr 1, 2021
Maintains: Buy
Price Target: $480 → $640
Current: $1.75
Upside: +36,471.43%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $10.76
Upside: +76.66%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.19
Upside: -